MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Omega Diagnostics to post first-half loss as revenue slides 29%

StockMarketWire.com

Disease test-kit supplier Omega Diagnostics warned it would post a first-half loss amid a 29% drop in revenue.

Losses at the earnings before interest, tax, depreciation and amortisation level for the six months through September were expected at around £1.3 million.

Revenue was seen dropping to £3.2 million, down from £4.5 million year-on-year.

'These results are in line with management's expectation at the half-year stage and reflect a predicted impact on the short-term performance of our food intolerance business due to the coronavirus pandemic as detailed in our results to 31 March 2020,' the company said.

Cash at 30 September was £7.0 million, which Omega Diagnostics said was in line with expectation, given the trading performance and capital investment in plant and machinery made to support Covid-19 opportunities.

'The board remains confident in the company's prospects and has made substantial progress over recent months in positioning the business for a significantly improved performance in the second half of the financial year,' it said.





Story provided by StockMarketWire.com